The global Prostate Cancer Diagnostics and Therapy market was valued at US$ 13430 million in 2023 and is anticipated to reach US$ 17600 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.

Prostate Cancer Diagnostics and Therapy Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics and Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics and Therapy.

Report Scope

The Prostate Cancer Diagnostics and Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Diagnostics and Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate Cancer Diagnostics and Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Prostate Cancer Diagnostics and Therapy Market Report

Report Metric	Details
Report Name	Prostate Cancer Diagnostics and Therapy Market
Accounted market size in 2023	US$ 13430 million
Forecasted market size in 2030	US$ 17600 million
CAGR	4.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Androgen Receptor-Directed Therapy Taxane-Based Chemotherapy
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ipsen SA, Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Abbvie Inc., Merck & Co. Inc., AstraZeneca PLC, Thermo Fisher Scientific, Dendreon Pharmaceuticals LLC, F. Hoffmann-La Roche Ltd, Hologic Inc., Astellas Pharma Inc., Koninklijke Philips NV, Sanofi-Aventis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics and Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Prostate Cancer Diagnostics and Therapy Market growing?

Ans: The Prostate Cancer Diagnostics and Therapy Market witnessing a CAGR of 4.0% during the forecast period 2024-2030.

What is the Prostate Cancer Diagnostics and Therapy Market size in 2030?

Ans: The Prostate Cancer Diagnostics and Therapy Market size in 2030 will be US$ 17600 million.

Who are the main players in the Prostate Cancer Diagnostics and Therapy Market report?

Ans: The main players in the Prostate Cancer Diagnostics and Therapy Market are Ipsen SA, Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Abbvie Inc., Merck & Co. Inc., AstraZeneca PLC, Thermo Fisher Scientific, Dendreon Pharmaceuticals LLC, F. Hoffmann-La Roche Ltd, Hologic Inc., Astellas Pharma Inc., Koninklijke Philips NV, Sanofi-Aventis

What are the Application segmentation covered in the Prostate Cancer Diagnostics and Therapy Market report?

Ans: The Applications covered in the Prostate Cancer Diagnostics and Therapy Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Prostate Cancer Diagnostics and Therapy Market report?

Ans: The Types covered in the Prostate Cancer Diagnostics and Therapy Market report are Androgen Receptor-Directed Therapy, Taxane-Based Chemotherapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Androgen Receptor-Directed Therapy

1.2.3 Taxane-Based Chemotherapy

1.3 Market by Application

1.3.1 Global Prostate Cancer Diagnostics and Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Cancer Diagnostics and Therapy Market Perspective (2019-2030)

2.2 Prostate Cancer Diagnostics and Therapy Growth Trends by Region

2.2.1 Global Prostate Cancer Diagnostics and Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Prostate Cancer Diagnostics and Therapy Historic Market Size by Region (2019-2024)

2.2.3 Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Region (2025-2030)

2.3 Prostate Cancer Diagnostics and Therapy Market Dynamics

2.3.1 Prostate Cancer Diagnostics and Therapy Industry Trends

2.3.2 Prostate Cancer Diagnostics and Therapy Market Drivers

2.3.3 Prostate Cancer Diagnostics and Therapy Market Challenges

2.3.4 Prostate Cancer Diagnostics and Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Prostate Cancer Diagnostics and Therapy Players by Revenue

3.1.1 Global Top Prostate Cancer Diagnostics and Therapy Players by Revenue (2019-2024)

3.1.2 Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Prostate Cancer Diagnostics and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Prostate Cancer Diagnostics and Therapy Revenue

3.4 Global Prostate Cancer Diagnostics and Therapy Market Concentration Ratio

3.4.1 Global Prostate Cancer Diagnostics and Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics and Therapy Revenue in 2023

3.5 Prostate Cancer Diagnostics and Therapy Key Players Head office and Area Served

3.6 Key Players Prostate Cancer Diagnostics and Therapy Product Solution and Service

3.7 Date of Enter into Prostate Cancer Diagnostics and Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Diagnostics and Therapy Breakdown Data by Type

4.1 Global Prostate Cancer Diagnostics and Therapy Historic Market Size by Type (2019-2024)

4.2 Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Type (2025-2030)

5 Prostate Cancer Diagnostics and Therapy Breakdown Data by Application

5.1 Global Prostate Cancer Diagnostics and Therapy Historic Market Size by Application (2019-2024)

5.2 Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Prostate Cancer Diagnostics and Therapy Market Size (2019-2030)

6.2 North America Prostate Cancer Diagnostics and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024)

6.4 North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Prostate Cancer Diagnostics and Therapy Market Size (2019-2030)

7.2 Europe Prostate Cancer Diagnostics and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024)

7.4 Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size (2019-2030)

8.2 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Prostate Cancer Diagnostics and Therapy Market Size (2019-2030)

9.2 Latin America Prostate Cancer Diagnostics and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024)

9.4 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size (2019-2030)

10.2 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Ipsen SA

11.1.1 Ipsen SA Company Detail

11.1.2 Ipsen SA Business Overview

11.1.3 Ipsen SA Prostate Cancer Diagnostics and Therapy Introduction

11.1.4 Ipsen SA Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.1.5 Ipsen SA Recent Development

11.2 Pfizer Inc.

11.2.1 Pfizer Inc. Company Detail

11.2.2 Pfizer Inc. Business Overview

11.2.3 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Introduction

11.2.4 Pfizer Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.2.5 Pfizer Inc. Recent Development

11.3 Johnson & Johnson Services Inc.

11.3.1 Johnson & Johnson Services Inc. Company Detail

11.3.2 Johnson & Johnson Services Inc. Business Overview

11.3.3 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Introduction

11.3.4 Johnson & Johnson Services Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.3.5 Johnson & Johnson Services Inc. Recent Development

11.4 Bayer AG

11.4.1 Bayer AG Company Detail

11.4.2 Bayer AG Business Overview

11.4.3 Bayer AG Prostate Cancer Diagnostics and Therapy Introduction

11.4.4 Bayer AG Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.4.5 Bayer AG Recent Development

11.5 Abbvie Inc.

11.5.1 Abbvie Inc. Company Detail

11.5.2 Abbvie Inc. Business Overview

11.5.3 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Introduction

11.5.4 Abbvie Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.5.5 Abbvie Inc. Recent Development

11.6 Merck & Co. Inc.

11.6.1 Merck & Co. Inc. Company Detail

11.6.2 Merck & Co. Inc. Business Overview

11.6.3 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Introduction

11.6.4 Merck & Co. Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.6.5 Merck & Co. Inc. Recent Development

11.7 AstraZeneca PLC

11.7.1 AstraZeneca PLC Company Detail

11.7.2 AstraZeneca PLC Business Overview

11.7.3 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Introduction

11.7.4 AstraZeneca PLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.7.5 AstraZeneca PLC Recent Development

11.8 Thermo Fisher Scientific

11.8.1 Thermo Fisher Scientific Company Detail

11.8.2 Thermo Fisher Scientific Business Overview

11.8.3 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Introduction

11.8.4 Thermo Fisher Scientific Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.8.5 Thermo Fisher Scientific Recent Development

11.9 Dendreon Pharmaceuticals LLC

11.9.1 Dendreon Pharmaceuticals LLC Company Detail

11.9.2 Dendreon Pharmaceuticals LLC Business Overview

11.9.3 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Introduction

11.9.4 Dendreon Pharmaceuticals LLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.9.5 Dendreon Pharmaceuticals LLC Recent Development

11.10 F. Hoffmann-La Roche Ltd

11.10.1 F. Hoffmann-La Roche Ltd Company Detail

11.10.2 F. Hoffmann-La Roche Ltd Business Overview

11.10.3 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Introduction

11.10.4 F. Hoffmann-La Roche Ltd Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.10.5 F. Hoffmann-La Roche Ltd Recent Development

11.11 Hologic Inc.

11.11.1 Hologic Inc. Company Detail

11.11.2 Hologic Inc. Business Overview

11.11.3 Hologic Inc. Prostate Cancer Diagnostics and Therapy Introduction

11.11.4 Hologic Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.11.5 Hologic Inc. Recent Development

11.12 Astellas Pharma Inc.

11.12.1 Astellas Pharma Inc. Company Detail

11.12.2 Astellas Pharma Inc. Business Overview

11.12.3 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Introduction

11.12.4 Astellas Pharma Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.12.5 Astellas Pharma Inc. Recent Development

11.13 Koninklijke Philips NV

11.13.1 Koninklijke Philips NV Company Detail

11.13.2 Koninklijke Philips NV Business Overview

11.13.3 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Introduction

11.13.4 Koninklijke Philips NV Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.13.5 Koninklijke Philips NV Recent Development

11.14 Sanofi-Aventis

11.14.1 Sanofi-Aventis Company Detail

11.14.2 Sanofi-Aventis Business Overview

11.14.3 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Introduction

11.14.4 Sanofi-Aventis Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

11.14.5 Sanofi-Aventis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Ipsen SA

Pfizer Inc

Johnson & Johnson Services Inc.

Thermo Fisher Scientific

Dendreon Pharmaceuticals LLC.

F Hoffmann La Roche Ltd

Hologic Inc

Astellas Pharma Inc

Koninklijke Philips NV

Sanofi Aventis

List of Tables

Table 1. Global Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Androgen Receptor-Directed Therapy

Table 3. Key Players of Taxane-Based Chemotherapy

Table 4. Global Prostate Cancer Diagnostics and Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Prostate Cancer Diagnostics and Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Prostate Cancer Diagnostics and Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Prostate Cancer Diagnostics and Therapy Market Share by Region (2019-2024)

Table 8. Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Prostate Cancer Diagnostics and Therapy Market Share by Region (2025-2030)

Table 10. Prostate Cancer Diagnostics and Therapy Market Trends

Table 11. Prostate Cancer Diagnostics and Therapy Market Drivers

Table 12. Prostate Cancer Diagnostics and Therapy Market Challenges

Table 13. Prostate Cancer Diagnostics and Therapy Market Restraints

Table 14. Global Prostate Cancer Diagnostics and Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Prostate Cancer Diagnostics and Therapy Market Share by Players (2019-2024)

Table 16. Global Top Prostate Cancer Diagnostics and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics and Therapy as of 2023)

Table 17. Ranking of Global Top Prostate Cancer Diagnostics and Therapy Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics and Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Prostate Cancer Diagnostics and Therapy Product Solution and Service

Table 21. Date of Enter into Prostate Cancer Diagnostics and Therapy Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Prostate Cancer Diagnostics and Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global Prostate Cancer Diagnostics and Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Application (2019-2024)

Table 29. Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Application (2025-2030)

Table 31. North America Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. Ipsen SA Company Detail

Table 47. Ipsen SA Business Overview

Table 48. Ipsen SA Prostate Cancer Diagnostics and Therapy Product

Table 49. Ipsen SA Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 50. Ipsen SA Recent Development

Table 51. Pfizer Inc. Company Detail

Table 52. Pfizer Inc. Business Overview

Table 53. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Product

Table 54. Pfizer Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 55. Pfizer Inc. Recent Development

Table 56. Johnson & Johnson Services Inc. Company Detail

Table 57. Johnson & Johnson Services Inc. Business Overview

Table 58. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Product

Table 59. Johnson & Johnson Services Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 60. Johnson & Johnson Services Inc. Recent Development

Table 61. Bayer AG Company Detail

Table 62. Bayer AG Business Overview

Table 63. Bayer AG Prostate Cancer Diagnostics and Therapy Product

Table 64. Bayer AG Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 65. Bayer AG Recent Development

Table 66. Abbvie Inc. Company Detail

Table 67. Abbvie Inc. Business Overview

Table 68. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Product

Table 69. Abbvie Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 70. Abbvie Inc. Recent Development

Table 71. Merck & Co. Inc. Company Detail

Table 72. Merck & Co. Inc. Business Overview

Table 73. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Product

Table 74. Merck & Co. Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 75. Merck & Co. Inc. Recent Development

Table 76. AstraZeneca PLC Company Detail

Table 77. AstraZeneca PLC Business Overview

Table 78. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Product

Table 79. AstraZeneca PLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 80. AstraZeneca PLC Recent Development

Table 81. Thermo Fisher Scientific Company Detail

Table 82. Thermo Fisher Scientific Business Overview

Table 83. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Product

Table 84. Thermo Fisher Scientific Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 85. Thermo Fisher Scientific Recent Development

Table 86. Dendreon Pharmaceuticals LLC Company Detail

Table 87. Dendreon Pharmaceuticals LLC Business Overview

Table 88. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Product

Table 89. Dendreon Pharmaceuticals LLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 90. Dendreon Pharmaceuticals LLC Recent Development

Table 91. F. Hoffmann-La Roche Ltd Company Detail

Table 92. F. Hoffmann-La Roche Ltd Business Overview

Table 93. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Product

Table 94. F. Hoffmann-La Roche Ltd Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 95. F. Hoffmann-La Roche Ltd Recent Development

Table 96. Hologic Inc. Company Detail

Table 97. Hologic Inc. Business Overview

Table 98. Hologic Inc. Prostate Cancer Diagnostics and Therapy Product

Table 99. Hologic Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 100. Hologic Inc. Recent Development

Table 101. Astellas Pharma Inc. Company Detail

Table 102. Astellas Pharma Inc. Business Overview

Table 103. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Product

Table 104. Astellas Pharma Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 105. Astellas Pharma Inc. Recent Development

Table 106. Koninklijke Philips NV Company Detail

Table 107. Koninklijke Philips NV Business Overview

Table 108. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Product

Table 109. Koninklijke Philips NV Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 110. Koninklijke Philips NV Recent Development

Table 111. Sanofi-Aventis Company Detail

Table 112. Sanofi-Aventis Business Overview

Table 113. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Product

Table 114. Sanofi-Aventis Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)

Table 115. Sanofi-Aventis Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Prostate Cancer Diagnostics and Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Prostate Cancer Diagnostics and Therapy Market Share by Type: 2023 VS 2030

Figure 3. Androgen Receptor-Directed Therapy Features

Figure 4. Taxane-Based Chemotherapy Features

Figure 5. Global Prostate Cancer Diagnostics and Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Prostate Cancer Diagnostics and Therapy Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Clinics Case Studies

Figure 9. Others Case Studies

Figure 10. Prostate Cancer Diagnostics and Therapy Report Years Considered

Figure 11. Global Prostate Cancer Diagnostics and Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Prostate Cancer Diagnostics and Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Prostate Cancer Diagnostics and Therapy Market Share by Region: 2023 VS 2030

Figure 14. Global Prostate Cancer Diagnostics and Therapy Market Share by Players in 2023

Figure 15. Global Top Prostate Cancer Diagnostics and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics and Therapy as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics and Therapy Revenue in 2023

Figure 17. North America Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Prostate Cancer Diagnostics and Therapy Market Share by Country (2019-2030)

Figure 19. United States Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Prostate Cancer Diagnostics and Therapy Market Share by Country (2019-2030)

Figure 23. Germany Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Share by Region (2019-2030)

Figure 31. China Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Prostate Cancer Diagnostics and Therapy Market Share by Country (2019-2030)

Figure 39. Mexico Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Share by Country (2019-2030)

Figure 43. Turkey Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Ipsen SA Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 46. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 47. Johnson & Johnson Services Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 48. Bayer AG Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 49. Abbvie Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 50. Merck & Co. Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 51. AstraZeneca PLC Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 53. Dendreon Pharmaceuticals LLC Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 54. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 55. Hologic Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 56. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 57. Koninklijke Philips NV Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 58. Sanofi-Aventis Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024

Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Guidewire Market Research Report 2024

Global Kidney Cancer Diagnosis Market Research Report 2025

Global Advanced Prostate Cancer Drug Market Research Report 2025

Global Gynecological Cancers Drug Market Research Report 2025

Global Reproductive and Fertility Diagnosis Market Research Report 2025

AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Premium Diagnostic Radiology Monitors Market Research Report 2025

Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Still s Disease Treatment Market Research Report 2025

Global Radiotherapy Device Market Research Report 2024

Global Treatment Planning Software Market Research Report 2025

Global Automated Clinical Diagnostic System Market Research Report 2024

Global Coding and Marking for Pharmaceuticals and Consumer Products Market Research Report 2024

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Validation Services Market Research Report 2025

Global Drugs of Abuse Testing Market Research Report 2024

Global AI Image assisted Diagnosis Software Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions